Abstract:OBJECTIVE:To explore the specific expression of HSV-tk gene and killing effects on ocular leading cells of the enhanced specific HSV-tk/GCV gene therapy system regulated by lens-specific promoter LEP503.METHODS:Experimental research. The enhanced specific HSV-tk/GCV gene system of two vectors were constructed (Lenti-LEP503-HSVtk-Cre and Lenti-HPGK-Loxp-EGFP-pA-Loxp-HSVtk). The lentiviral vectors were produced by transient transduction of transfering vectors, packaging vectors and enveloping vector into 293T cells. Virus was collected with ultracentrifugation and resuspended with 1 ml phosphate buffered saline and stored at -80°C. The HLEC and RPEC, NIH3T3, 293T cells were transduced with the enhanced specific HSV-tk gene system. The specific expressions of EGFP and HSV-tk were detected by fluorescence microscopy, flow cytometry and RT-PCR. The killing effects of HLEC and RPEC at the concentration of 20 mg/L GCV were assayed and compared by flow cytometry and CCK-8 kit. Difference of RPE cell viability among groups was evaluated by analysis of variance (ANOVA).RESULTS:Expression efficiency of EGFP in RPEC group was 62.3%, 68.3% in NIH3T3 group, 75.8% in 293T group, whereas 17.5% in HLEC group. There was higher expression of HSV-tk at mRNA level in HLEC group than that in RPEC group. The relative intensity of HSV-tk mRNA in HLEC group transduced with the enhanced specific HSV-tk gene system was 4.01, whereas 0.29 in RPEC group. At the concentration of 20 mg/L GCV after 72 hours, the percentage of apoptosis detected by the flow cytometry in HLEC group transduced by the enhanced specific HSV-tk gene system was 76.51%, and 2.44% in RPEC group. There was no significant difference in the RPE cell viability among the enhanced specific HSV-tk gene combination-RPE group, normal-RPE group and negative-RPE control group at the concentration of 20 mg/L GCV after 72 hours (MD(1) = -0.047, P = 0.671; MD(2) = 0.027, P = 0.912).CONCLUSIONS:The enhanced specific HSV-tk gene system express HSV-tk selectively in HLEC. At the concentration of 20 mg/L GCV, it is effective against the proliferation of HLEC in vitro, but has less kill effect on RPEC.

Vesicular stomatitis virus G-protein retrovector mediated a herpes simplex virus thymidine kinase gene transduction and expression in the human retinal pigment epithelial cells

Efficient establishment of reactivatable latency by an acyclovir-resistant herpes simplex virus 1 thymidine kinase substitution mutant with reduced neuronal replication.

Killing effect of mutant herpes simplex virus type 1 thymidine kinase on rat C6 glioma cells

Gene Therapy with HSV1-sr39TK/GCV Exhibits a Stronger Therapeutic Efficacy Than HSV1-TK/GCV in Rat C6 Glioma Cells

Rerovirus Mediated Hsv-Tk Gene Transfer Can Influence The Function Of Human T-Lymphocyte

Transfection and expression of retrovirus-mediated reporter genes in retinal pigment epithelial cells in vitro

[The Cell-Type-specific HSV-tk Gene Expression of Suicide Gene Therapy System Regulated by Lens-Specific Promoter LEP503].

[Construction and Identification of Recombinant Vectors Carrying Herpes Simplex Virus Thymidine Kinase Genes Expressed in Vascular Endothelial Cells].

Construction of lentiviral vector plasmid containing thymidine kinase gene and establishment of an expression system

Acute and long term toxicity effects of herpes simplex virus Ⅰ thymidine kinase gene and ganciclovir system in non-human primates

An in Vitro Study of a Conditionally Replicative Adenovirus Delivering the Herpes Simplex Virus Thymidine Kinase Suicide Gene in Retinoblastoma

[Effects of herpes simplex virus thymidine kinase gene transduction and prodrug on ovarian cancer cell]

The Effect of Lentivirus-Mediated Suicide Gene Therapy on Lens Epithelial Cells

[Experimental Study on Human Glioma SHG44 Treated by HSV-tk Gene Therapy].

Selective Killing of TK Gene Transfected Lymphoma Cell Lines by Ganciclovir

Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model.

High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection.

Construction of the package cells( PA317/TK) with recombinant retroviral vector containing HSVtk gene

[The Effect of HSV-tk/GCV on Hepatic Specific Damage Driven by Murine ALB Promoter/enhancer].

Characteristics of Ovarian Cancer Cells Transduced by the Bicistronic Retroviral Vector Containing GM-CSF and HSV-TK Genes.

Efficient retinal ganglion cells transduction by retro-orbital venous sinus injection of AAV-PHP.eB in mature mice